VERSARIEN PLC

AGM Information • Jan 10, 2024

National Storage Mechanism | Additional information

RNS Number : 2717Z

Versarien PLC

10 January 2024

10 January 2024

Versarien Plc

("Versarien" or the "Company")

Result of General Meeting

Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's General Meeting held earlier today, all resolutions were duly passed.  Full details of the resolutions are set out in the Notice of General Meeting dated 20 December 2023 and available on the Company's website at: https://www.versarien.com/investors/reports-and-presentations/

The proxy votes cast were as follows:

Resolution	For		Against		Abstain
1 - to sub-divide each Existing Ordinary Share into one New Ordinary Share and one New Deferred Share	22,939,297	93.25%	1,661,734	6.75%	303,606
2 - a special resolution to alter the Articles to allow for the issue of New Deferred Shares by including provisions relating to the rights and restrictions attached to the New Deferred Shares	22,992,555	93.78%	1,524,588	6.22%	387,494
3 - to grant the directors authority to allot up to 992,339,000 New Ordinary Shares	22,754,233	93.16%	1,670,424	6.84%	479,980
4 - a special resolution to grant the directors authority to allot up to 992,339,000 New Ordinary Shares for cash without first offering them to existing shareholders	22,530,861	92.30%	1,880,416	7.70%	493,360

Share Capital Reorganisation

Following the passing of the resolutions at the General Meeting, each of the Company's 496,169,507 Existing Ordinary Shares will be sub-divided into one New Ordinary Share of 0.01p (the "New Ordinary Shares") and one deferred share of 0.09p ("New Deferred Shares"). The New Deferred Shares will have little economic value as they will not carry any rights to vote or dividend rights, although the New Deferred Shares will rank pari passu with the New Ordinary Shares on a return of capital or on a winding up of the Company.

Admission to AIM and Total Voting Rights

Dealings on AIM in the Existing Ordinary Shares is expected to cease at the close of business on 10 January 2024. Application has been made for the admission of 496,169,507 New Ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading in the New Ordinary Shares will commence at 8.00 a.m. on or around 11 January 2024. No application will be made for admission of the New Deferred Shares to trading on AIM nor will any such application be made to any other exchange.

Following Admission, there will be a total of 496,169,507 New Ordinary Shares, with voting rights, in issue. The Company does not hold any shares in treasury. Consequently, 496,169,507 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise indicated, all defined terms in this announcement shall have the same meaning as described in the Company's announcement dated 20 December 2023 and the Circular which was posted to shareholders on the same day.

For further information please contact:

Versarien Stephen Hodge, Chief Executive Officer Chris Leigh, Chief Financial Officer	c/o IFC
SP Angel Corporate Finance (Nominated Adviser and Broker) Matthew Johnson, Adam Cowl	+44 (0)20 3470 0470
IFC Advisory Limited (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen	+44 (0) 20 3934 6630

For further information please see: http://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMGPURPGUPCGGU